Memorial Sloan-Kettering
Sophia Genetics Q3 Revenues Fall 3 Percent
Expected softness in its biopharma customer segment was buoyed by record analysis volume for its Sophia DDM genomic analysis software platform.
Sophia sponsored a meeting gathering early adopters, pharma partners, and others to discuss the recently launched MSK-ACCESS, and soon-to-launch MSK-IMPACT kits.
Biden Cancer Moonshot Announces New Projects Focused on Decreasing Cancer Burden in Africa
Programs aim to improve screening tools and adherence, advance new point-of-care diagnostics, and increase access to precision medicine on the continent.
Sophia Genetics Sees Profitability in Next Two Years, Touts Liquid Biopsy Potential at JP Morgan
Sophia execs said the firm added 35 new core genomics customers in the fourth quarter of 2023 and 87 over the full year.
Sophia Genetics, Memorial Sloan Kettering, AstraZeneca Partner to Broaden Cancer Sequencing Access
The companies aim to create a decentralized global network for genomic cancer testing, including underserved regions where access remains limited.